Literature DB >> 17465444

Multifactorial nature of hepatocellular carcinoma drug resistance: could plant polyphenols be helpful?

Natale D'Alessandro1, Paola Poma, Giuseppe Montalto.   

Abstract

Primary hepatocellular carcinoma (HCC) is a quite frequent tumor which results in high mortality and most often exhibits a poor response to present drug therapies. Clearly, a thorough understanding of the biological bases of this malignancy might suggest new strategies for its treatment. Here we examine the evidences that both "pharmacological" mechanisms (e.g. drug transporter or detoxification enzyme over-expression) and alterations in other critical factors, including the IAPs (Inhibitory of Apoptosis Proteins), involved in enhancement of cell survival and proliferation may determine the therapeutic resistance of HCC; we also underline the possible role in the process of the activation of transcription factors, like NF-kappaB, capable of contemporaneously up-regulating the mechanisms discussed. On this basis, we finally comment on the possible use of natural multi-targeted antitumoral agents like plant polyphenols to achieve sensitization to treatments in HCC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17465444      PMCID: PMC4319121          DOI: 10.3748/wjg.v13.i14.2037

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  77 in total

Review 1.  Using chemopreventive agents to enhance the efficacy of cancer therapy.

Authors:  Fazlul H Sarkar; Yiwei Li
Journal:  Cancer Res       Date:  2006-04-01       Impact factor: 12.701

2.  Survivin overexpression in hepatocellular carcinoma is associated with p53 dysregulation.

Authors:  Rajesh Kannangai; Jianzhou Wang; Qiong Z Liu; Fikret Sahin; Michael Torbenson
Journal:  Int J Gastrointest Cancer       Date:  2005

Review 3.  Expression of IAPs and alternative splice variants in hepatocellular carcinoma tissues and cells.

Authors:  Monica Notarbartolo; Melchiorre Cervello; Lydia Giannitrapani; Maria Meli; Paola Poma; Luisa Dusonchet; Giuseppe Montalto; Natale D'Alessandro
Journal:  Ann N Y Acad Sci       Date:  2004-12       Impact factor: 5.691

4.  Dynamic expression of apoptosis-related genes during development of laboratory hepatocellular carcinoma and its relation to apoptosis.

Authors:  Xiao-Xian Duan; Jing-Sheng Ou; Yuan Li; Jian-Jia Su; Chao Ou; Chun Yang; Hui-Fen Yue; Ke-Chen Ban
Journal:  World J Gastroenterol       Date:  2005-08-14       Impact factor: 5.742

5.  Clinical value of apoptosis and angiogenesis factors in estimating the prognosis of hepatocellular carcinoma.

Authors:  Rong-Ping Guo; Chong Zhong; Ming Shi; Chang-Qing Zhang; Wei Wei; Ya-Qi Zhang; Jin-Qing Li
Journal:  J Cancer Res Clin Oncol       Date:  2006-06-09       Impact factor: 4.553

6.  Doxorubicin for unresectable hepatocellular carcinoma. A prospective study on the addition of verapamil.

Authors:  E C Lai; T K Choi; C H Cheng; F P Mok; S T Fan; E S Tan; J Wong
Journal:  Cancer       Date:  1990-10-15       Impact factor: 6.860

7.  The expression of cytochrome P-450, epoxide hydrolase, and glutathione S-transferase in hepatocellular carcinoma.

Authors:  G I Murray; P J Paterson; R J Weaver; S W Ewen; W T Melvin; M D Burke
Journal:  Cancer       Date:  1993-01-01       Impact factor: 6.860

8.  Antitumor effects of the novel NF-kappaB inhibitor dehydroxymethyl-epoxyquinomicin on human hepatic cancer cells: analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production.

Authors:  Paola Poma; Monica Notarbartolo; Manuela Labbozzetta; Rosario Sanguedolce; Alessandra Alaimo; Valeria Carina; Annamaria Maurici; Antonella Cusimano; Melchiorre Cervello; Natale D'Alessandro
Journal:  Int J Oncol       Date:  2006-04       Impact factor: 5.650

Review 9.  The inhibitors of apoptosis (IAPs) and their emerging role in cancer.

Authors:  E C LaCasse; S Baird; R G Korneluk; A E MacKenzie
Journal:  Oncogene       Date:  1998-12-24       Impact factor: 9.867

10.  Expression of survivin mRNA associates with apoptosis, proliferation and histologically aggressive features in hepatocellular carcinoma.

Authors:  Soichiro Morinaga; Yoshiyasu Nakamura; Naoki Ishiwa; Takaki Yoshikawa; Yoshikazu Noguchi; Yuji Yamamoto; Yasushi Rino; Toshio Imada; Yoshinori Takanashi; Makoto Akaike; Yukio Sugimasa; Shoji Takemiya
Journal:  Oncol Rep       Date:  2004-12       Impact factor: 3.906

View more
  7 in total

Review 1.  Identifying the targets for treatment of liver fibrosis and hepatocellular carcinoma from both Western medicine and Chinese medicine.

Authors:  Yuewen Gong
Journal:  Chin J Integr Med       Date:  2012-03-30       Impact factor: 1.978

2.  Indole-3-carbinol inhibits tumorigenicity of hepatocellular carcinoma cells via suppression of microRNA-21 and upregulation of phosphatase and tensin homolog.

Authors:  Xinmei Wang; Hongyan He; Yuanzhi Lu; Wei Ren; Kun-Yu Teng; Chi-Ling Chiang; Zhaogang Yang; Bo Yu; Shuhao Hsu; Samson T Jacob; Kalpana Ghoshal; L James Lee
Journal:  Biochim Biophys Acta       Date:  2014-10-25

3.  Diallyl sulfide protects against N-nitrosodiethylamine-induced liver tumorigenesis: role of aldose reductase.

Authors:  Safinaz-S Ibrahim; Noha-N Nassar
Journal:  World J Gastroenterol       Date:  2008-10-28       Impact factor: 5.742

4.  In vivo modulation of iNOS pathway in hepatocellular carcinoma by Nigella sativa.

Authors:  Moustafa Fathy; Toshio Nikaido
Journal:  Environ Health Prev Med       Date:  2013-04-23       Impact factor: 3.674

5.  Potential targets for molecular imaging of apoptosis resistance in hepatocellular carcinoma.

Authors:  Z Liu; M Cheng; Mz Cao
Journal:  Biomed Imaging Interv J       Date:  2011-01-01

6.  Tannic acid mediated induction of apoptosis in human glioma Hs 683 cells.

Authors:  Jian Zhang; Dong Chen; Dian-Ming Han; Yan-Hao Cheng; Chao Dai; Xiu-Jie Wu; Feng-Yuan Che; Xue-Yuan Heng
Journal:  Oncol Lett       Date:  2018-03-07       Impact factor: 2.967

7.  Synthesis of Curcumin Derivatives and Analysis of Their Antitumor Effects in Triple Negative Breast Cancer (TNBC) Cell Lines.

Authors:  Paola Maria Bonaccorsi; Manuela Labbozzetta; Anna Barattucci; Tania Maria Grazia Salerno; Paola Poma; Monica Notarbartolo
Journal:  Pharmaceuticals (Basel)       Date:  2019-10-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.